Sensiotec Inc. has developed the Virtual Medical Assistant® (VMA), the world’s first truly remote, noncontact, cardiorespiratory patient monitoring platform. The VMA recalls the StarTrek Tricorder, providing critical spot and trend data continuously to a nurse’s station, tablet, smartphone or pager without electrodes touching the patient or pads requiring contact with a mattress or other surface. As a decision support tool, the VMA can help identify potential healthcare crises at an early stage and reduce complications associated with certain common chronic illnesses. It offers usability, scalability, and interoperability, including the capability to integrate data from third party devices such as Bluetooth® SpO2, blood pressure, and weight scale monitors. The VMA can provide high value, low cost, location-agnostic monitoring solutions to reduce risk, improve care, increase productivity, and help satisfy meaningful use requirements when paired with an EMR.
Sensiotec Inc. is based in Atlanta, Georgia at the Georgia Tech Venture Center, part of the Georgia Institute of Technology’s innovative Tech Square community, named by Forbes as one of the “Top 12 Business Incubators Changing the World”. At the heart of it all, they are at the cornerstone of next-generation smart healthcare, telemedicine, telehealth, mHealth, e-medicine, remote e-health services and the health home. Among healthcare technology’s pioneers and game changers, Sensiotec Inc. is in great company.
Founded in 2008, Sensiotec Inc. operates in the Health Care industry with headquarters in the United States. The most recent investment was a Seed Round investment at 15 January 2014 led by ATDC.